Edesa Biotech, Inc. — Director's Dealing 2023

Jul 24, 2023

SEC Form 4/A — Form 4/A

Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2023-07-20

Reporting Person: MacDonald Sean Arthur (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-20	Share Option (right to buy)	$0.8277	A	20000	Acquired	2033-07-20	Common Shares (20000)	Direct

Footnotes

F1: This option vests monthly in equal proportions over 12 months beginning on the date of grant.